Leading medical laboratories and pharmaceutical manufactures are utilizing cluster-computing architectures to enable their commercial and proprietary applications in business areas such as drug discovery and clinical development.

By using QLogic products to provide high performance, low latency interconnect of cluster computing resources, customers can improve the accuracy of research projects that require statistical analysis, molecular modeling, or computational chemistry while getting more work done in shorter timeframes at an increased return on investment.

• Drug Discovery: From sequence analysis to virtual high-throughput screening, computer simulation tools require high-performance compute power to process growing amounts of available data. By using QLogic high performance cluster interconnect solutions to enable the latest commercial or proprietary parallel processing tools, organizations can process wider molecular libraries in search of new leads, and can run jobs concurrently for reduced project timelines.
  
• Clinical Development: Customers can improve the speed and scope of PK/PD and other clinical data analysis tools by using QLogic high performance interconnect for computing grids to run jobs concurrently—now thousands of models can be analyzed at a time.
  
• Business Intelligence: Running ETL and other data management tools on a QLogic interconnected computing cluster can accelerate critical prescription data mining and reporting projects. This means minimized project timelines, improved accuracy and scope in reporting, and ultimately improved decision-making as well as better utilization of existing resources.

Expand Scope of Research and Analysis

QLogic products enable bioscience companies to bring superior products to market more efficiently by impacting multiple areas of the drug delivery process from early research to portfolio strategy in clinical trials to business analytics for improved strategic decision-making. QLogic interconnected computing clusters can run applications faster, process more data, and return more reliable results.

Speed Product Time to Market

QLogic solutions can help accelerate the drug development process by reducing the time it takes to get results, increasing the productivity of researchers, and helping to identify costly false leads more effectively. Computing clusters utilizing QLogic solutions can process data and return results far more rapidly, reducing the overall time for a drug to become commercially available.

Reduce or Eliminate Costs

In addition to the savings from reducing the time to bring a drug to market, QLogic’s products enable companies to increase ROI by pooling existing servers, workstations, and storage resources into a scalable grid computing architecture that can be centrally managed and shared.